Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial
暂无分享，去创建一个
S. Ou | Keunchil Park | Dong-Wan Kim | B. Cho | Sang-We Kim | J. Curtin | A. Roshak | Ji-Youn Han | E. Haura | R. Knoblauch | A. Spira | K. Lee | R. Sanborn | M. Thayu | M. Nagasaka | A. Minchom | J. Sabari | Jong-Seok Lee | Patricia A Lorenzini | Joshua M Bauml | Eun Kyung Cho | Jorge E. Gomez | Grace Gao | John Xie